M&T Bank
IOVA icon

M&T Bank’s Iovance Biotherapeutics IOVA Stock Holding History

M&T Bank’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,464
Closed -$31.3K – 1758
2025
Q4 		$31.3K Buy
+11,464
New +$26.5K ﹤0.01% 1669
2021
Q1 		– Sell
-13,786
Closed -$640K – 1635
2020
Q4 		$640K Buy
13,786
+840
+6% +$33.4K ﹤0.01% 935
2020
Q3 		$427K Buy
12,946
+2,697
+26% +$82.7K ﹤0.01% 1063
2020
Q2 		$281K Buy
10,249
+420
+4% +$13.8K ﹤0.01% 1223
2020
Q1 		$294K Sell
9,829
-1,171
-11% -$31K ﹤0.01% 1139
2019
Q4 		$304K Hold
11,000
– – ﹤0.01% 1079
2019
Q3 		$200K Hold
11,000
– – ﹤0.01% 1433
2019
Q2 		$270K Buy
+11,000
New +$166K ﹤0.01% 1281

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return